Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.
null nullnull nullEmily SammonsJ C HopewellF ChenW StevensK WallendszusE Valdes-MarquezR DayanandanC KnottK MurphyE WincottA BaxterR GoodenoughM LayM HillS MacdonnellG FabbriD LucciM Fajardo-MoserS BrennerD HaoH ZhangJ LiuB WuhanS MosegaardW HerringtonC WannerC AngermannG ErtlA MaggioniP BarterB MihaylovaY MitchelR BlausteinS GotoJ TobertP DeLuccaY ChenZ ChenA GrayR HaynesJ ArmitageC BaigentS WiviottC CannonE BraunwaldRory CollinsL BowmanMartin J Landraynull nullPublished in: European heart journal (2022)
International Standard Randomized Controlled Trial Number (ISRCTN) 48678192; ClinicalTrials.gov No. NCT01252953; EudraCT No. 2010-023467-18.